glp-1 psoriasis Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology | Diabetologia glp 1 for psoriatic arthritis

Duration Ongoing (long-term use expected) Repeatable Yes CMP (Comprehensive Metabolic Panel) When: Baseline Why: Baseline liver and kidney function Lipid panel When: Baseline Why: Baseline cardiovascular risk assessment HbA1c When: Baseline Why: Baseline glycemic status CMP When: 12 weeks Why: Monitor liver and kidney function during treatment Get weekly peptide research summaries, new study alerts, and protocol updates free

In response to cold conditions and excessive food intake, WAT lipolysis promotes acylcarnitine production in the liver

Breast, liver, colorectal and non-small cell lung cancer risks declined significantly

However, there are differences in affinities of the two peptides for the different GAL receptors